330 related articles for article (PubMed ID: 1202608)
21. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
22. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
Ruddy S; Fearon DT; Austen KF
Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
[TBL] [Abstract][Full Text] [Related]
23. Immunoglobulins and complement components in synovial fluid of patients with acute rheumatic fever.
Svartman M; Potter EV; Poon-King T; Earle DP
J Clin Invest; 1975 Jul; 56(1):111-7. PubMed ID: 1141429
[TBL] [Abstract][Full Text] [Related]
24. Complement determinations in the synovial fluid and serum of a patient with Erythema nodosum leprosum.
Louie JS; Glovsky M
Int J Lepr Other Mycobact Dis; 1975; 43(3):252-5. PubMed ID: 1240873
[TBL] [Abstract][Full Text] [Related]
25. [Activated C3 in the synovial fluid of patients with rheumatoid arthritis and arthrosis (correlations with C3, C4 and C3 proactivator/modification caused by storage)].
Hasler F; Stojan B
Z Rheumatol; 1981; 40(1):40-3. PubMed ID: 6908792
[TBL] [Abstract][Full Text] [Related]
26. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
Perrin LH; Nydegger UE; Zubler RH; Lambert PH; Miescher PA
Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
[TBL] [Abstract][Full Text] [Related]
27. Evidence for complement activation by the alternate pathway in the arthritis of hypogammaglobulinemic patients.
Munthe E; Hoyeraal HM; Froland SS; Mellbye OJ; Kåss E; Natvig JB
Rheumatology; 1975; 6():43-51. PubMed ID: 1081730
[TBL] [Abstract][Full Text] [Related]
28. [Complement in the synovial fluid. Diagnostic usefulness of its correction with protein fractions].
Gambari PF; Volante D; Stone GC; Ostuni PA; Ruffatti A; Punzi L; Todesco S
Recenti Prog Med; 1981 Jul; 71(1):69-75. PubMed ID: 7313285
[No Abstract] [Full Text] [Related]
29. Complement activation in rheumatoid arthritis evaluated by C3dg and the terminal complement complex.
Mollnes TE; Lea T; Mellbye OJ; Pahle J; Grand O; Harboe M
Arthritis Rheum; 1986 Jun; 29(6):715-21. PubMed ID: 3718564
[TBL] [Abstract][Full Text] [Related]
30. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
[TBL] [Abstract][Full Text] [Related]
31. Fibronectin in rheumatoid and non-rheumatoid arthritic synovial fluids and in synovial fluid cryoproteins.
Lu-Steffes M; Iammartino AJ; Schmid FR; Castor CW; Davis L; Entwistle R; Anderson B
Ann Clin Lab Sci; 1982; 12(3):178-85. PubMed ID: 7092168
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of C1q - binding to collagen - anticollagen immune complexes in synovial fluids of RA-patients.
Menzel J; Steffen C
Z Rheumatol; 1982; 41(2):47-9. PubMed ID: 6285637
[TBL] [Abstract][Full Text] [Related]
33. Cellular and humoral immune parameters of synovial fluid and blood in rheumatoid arthritis.
Dorwart BB; Hebert J; Schumacher HR; Abdou NI
J Rheumatol; 1975 Dec; 2(4):363-72. PubMed ID: 1082030
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
Mooney NA; Hay FC; Poulton TA
Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
[TBL] [Abstract][Full Text] [Related]
35. [The C'-3 constituent of the complement and rheumatoid factors in serum-synovial fluid paris in progressive polyarthritis and reactive synovites due to local causes (author's transl)].
Hrncír Z; Tichý M; Salavec M; Vavrina J
Cas Lek Cesk; 1976 Dec; 115(48):1487-90. PubMed ID: 1000565
[No Abstract] [Full Text] [Related]
36. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
[TBL] [Abstract][Full Text] [Related]
37. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
[TBL] [Abstract][Full Text] [Related]
38. [Study of the synovial fluid in rheumatoid arthritis].
Zakharova MM; Alekberova ZS; Trofimova TM; Riazantseva TA
Ter Arkh; 1988; 60(7):79-84. PubMed ID: 3212745
[TBL] [Abstract][Full Text] [Related]
39. The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes.
Hardin JA; Steere AC; Malawista SE
Yale J Biol Med; 1984; 57(4):589-93. PubMed ID: 6334939
[TBL] [Abstract][Full Text] [Related]
40. [The complement system].
Lambert PH
Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
